Here are five key notes:
1. Analysts have a one-year price target of $21 on Surgery Partners’ shares.
2. On Nov. 15, Zacks analysts downgraded Surgery Partners’ shares from a “buy” to a “hold” rating.
3. Surgery Partners has a one-year high of $22.32 and a one-year low of $11.76.
4. The company has a 50-day moving average of $18.13 and 200-day moving average of $17.28.
5. The market cap is $835.53 million.
More articles on surgery centers:
10 largest freestanding surgery centers: SK&A
Sparrow Health unveils $20M endoscopy and radiology center: 4 things to know
KeyCorp increases Surgery Partners’ yearly EPS estimate: 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
